[28PO1-am1] Drug information-4/Community pharmacy, home medical care, and community health care-3/Appropriate use of medicines (drug-drug interactions)-2/Pharmacotherapies (Personalized therapies)/Generic medicines/Others

[28PO1-am1-39S] Effect of the SLC5A2 polymorphism on the hypoglycemic and weight loss effects of SGLT2 inhibitors

○Kanon Sakai¹, Ayami Morita², Kentaro Oniki¹, Yuki Sakamoto¹, Ami Kondo¹, Moeka Matsuo¹, Akari Maruyama¹, Akira Yoshida², Hiroyuki Nishimura², Yuki Shioyama², Masafumi Takada², Hiroko Ijima², Fumio Miyamoto², Seigo Sugiyama², Kunio Hieshima², Noboru Kuriyama², Keizo Kajiwara², Katsunori Jinnouchi², Tomio Jinnouchi², Hideaki Jinnouchi², Junji Saruwatari¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Jinnouchi Hospital)